No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / complications
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / physiopathology
-
Disease-Free Survival
-
Drug Hypersensitivity / complications*
-
Drug Hypersensitivity / drug therapy
-
Drug Hypersensitivity / physiopathology
-
Drug Substitution
-
Humans
-
Idiopathic Pulmonary Fibrosis / chemically induced*
-
Idiopathic Pulmonary Fibrosis / drug therapy
-
Idiopathic Pulmonary Fibrosis / physiopathology
-
Lung Neoplasms / complications
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / physiopathology
-
Male
-
Middle Aged
-
Piperidines / administration & dosage
-
Piperidines / adverse effects*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Quinazolines / administration & dosage
-
Quinazolines / adverse effects*
-
Spirometry
-
Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*
Substances
-
Piperidines
-
Protein Kinase Inhibitors
-
Quinazolines
-
Vascular Endothelial Growth Factor Receptor-2
-
vandetanib